Sujun Han
Impact in
-
- Nanoparticle-Based Drug Delivery
Papers in
- Surgery 10
- Bladder and Urothelial Cancer Treatments 8
-
- Renal cell carcinoma treatment 3
- Ferroptosis and cancer prognosis 2
- Prostate Cancer Diagnosis and Treatment 2
- Co-authors
- Nianzeng Xing (17 shared papers)Feiya Yang (15 shared papers)Qinxin Zhao (5 shared papers)Lu Yin (2 shared papers)Wenkuan Wang (2 shared papers)Mingshuai Wang (2 shared papers)Dong Chen (2 shared papers)Boda Guo (2 shared papers)
- Journals
- Frontiers in Oncology (4 papers)Journal of Clinical Oncology (3 papers)Advanced Materials (2 papers)iScience (1 paper)Journal of Surgical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Sujun Han
22 papers receiving 492 citations
Sujun Han's Hit Papers
Peers
Comparison fields: 5 of 63
- Biomaterials 67
- Cancer Research 60
- Nutrition and Dietetics 61
- Biomedical Engineering 177
- Pulmonary and Respiratory Medicine 107
Countries citing papers authored by Sujun Han
This map shows the geographic impact of Sujun Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujun Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujun Han more than expected).
Fields of papers citing papers by Sujun Han
This network shows the impact of papers produced by Sujun Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujun Han. The network helps show where Sujun Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Sujun Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy Hit paper breakdown → | 2023 | 313 |
| 2 | 2023 | 73 | |
| 3 | 2021 | 13 | |
| 4 | 2022 | 11 | |
| 5 | Analysis of the status and trends of bladder cancer incidence in China | 2013 | 11 |
| 6 | 2021 | 11 | |
| 7 | 2020 | 9 | |
| 8 | 2019 | 9 | |
| 9 | 2023 | 7 | |
| 10 | 2024 | 5 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2021 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2021 | 3 | |
| 18 | 2019 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2012 | 1 |
About Sujun Han
Sujun Han is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Psychiatry and Mental health, having authored 25 papers that have together received 495 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (8 papers), Cancer Immunotherapy and Biomarkers (4 papers), Renal cell carcinoma treatment (3 papers), Advanced Nanomaterials in Catalysis (2 papers), Ferroptosis and cancer prognosis (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Biomaterials (67 citations), Cancer Research (60 citations), Nutrition and Dietetics (61 citations), Biomedical Engineering (177 citations) and Pulmonary and Respiratory Medicine (107 citations). Sujun Han has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Nianzeng Xing, Feiya Yang, Qinxin Zhao, Lu Yin, Wenkuan Wang, Mingshuai Wang, Dong Chen, Boda Guo, Lingpu Zhang and Haihua Xiao. Their work appears in journals such as Frontiers in Oncology, Journal of Clinical Oncology, Advanced Materials, iScience and Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.